Casper Steenholdt

3.3k total citations · 1 hit paper
85 papers, 2.4k citations indexed

About

Casper Steenholdt is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Casper Steenholdt has authored 85 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Genetics, 45 papers in Epidemiology and 38 papers in Immunology. Recurrent topics in Casper Steenholdt's work include Inflammatory Bowel Disease (64 papers), Microscopic Colitis (42 papers) and Immunodeficiency and Autoimmune Disorders (28 papers). Casper Steenholdt is often cited by papers focused on Inflammatory Bowel Disease (64 papers), Microscopic Colitis (42 papers) and Immunodeficiency and Autoimmune Disorders (28 papers). Casper Steenholdt collaborates with scholars based in Denmark, Germany and Norway. Casper Steenholdt's co-authors include Jørn Brynskov, Mark Ainsworth, Klaus Bendtzen, Ole Østergaard Thomsen, Gitte Pedersen, Ole Haagen Nielsen, Jens Kjeldsen, Lars Kristian Munck, Lisbet Ambrosius Christensen and Anne Sophie Oxholm and has published in prestigious journals such as Gastroenterology, Gut and Scientific Reports.

In The Last Decade

Casper Steenholdt

77 papers receiving 2.3k citations

Hit Papers

Individualised therapy is more cost-effective than dose i... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
    2013 361 citations Casper Steenholdt, Jørn Brynskov et al. Gut profile →

Peers

Casper Steenholdt
Bella Ungar Israel
Sofie Joossens Belgium
Bruce Salzberg United States
A. Cassinotti Italy
Stephan Targan United States
Xavier Hébuterne France
Liesbet Henckaerts Belgium
Sophie Candon France
Fabian Schnitzler Germany
Benjamin Pariente France
Bella Ungar Israel
Casper Steenholdt
Citations per year, relative to Casper Steenholdt Casper Steenholdt (= 1×) peers Bella Ungar

Countries citing papers authored by Casper Steenholdt

Since Specialization
Citations

This map shows the geographic impact of Casper Steenholdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casper Steenholdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casper Steenholdt more than expected).

Fields of papers citing papers by Casper Steenholdt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casper Steenholdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casper Steenholdt. The network helps show where Casper Steenholdt may publish in the future.

Co-authorship network of co-authors of Casper Steenholdt

This figure shows the co-authorship network connecting the top 25 collaborators of Casper Steenholdt. A scholar is included among the top collaborators of Casper Steenholdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casper Steenholdt. Casper Steenholdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johannesen, Katrine M., John Gásdal Karstensen, Emma Scott, et al.. (2025). A Novel Case of Biallelic MLH3 Variants in a Patient With Rectal Cancer and Polyps. Clinical Genetics. 107(4). 480–482. 3 indexed citations
2.
3.
Steenholdt, Casper, et al.. (2025). Identifying Genetic Factors Influencing the Development of Anti-Drug Antibodies in Inflammatory Bowel Disease: A Scoping Review. Journal of Inflammation Research. Volume 18. 17589–17610.
4.
Hausmann, Annika, Sophia Steigerwald, Alexandra Brand, et al.. (2025). Deep visual proteomics reveals an in vivo-like phenotype of orthotopically transplanted human colon organoids. Cell Systems. 16(9). 101396–101396.
5.
Berinstein, Jeffrey, Jakob Benedict Seidelin, Aurélien Amiot, et al.. (2025). Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy. Clinical Gastroenterology and Hepatology. 23(12). 2263–2271.e6.
6.
Larson, Carroll B., Jeffrey Berinstein, Jakob Benedict Seidelin, et al.. (2025). P0612 Postoperative outcomes in tofacitinib-treated patients with acute severe ulcerative colitis undergoing total abdominal colectomy. Journal of Crohn s and Colitis. 19(Supplement_1). i1212–i1212.
7.
Attauabi, Mohamed, Casper Steenholdt, John Gubatan, et al.. (2024). Network meta‐analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease. Alimentary Pharmacology & Therapeutics. 60(2). 124–143. 6 indexed citations
8.
Hausmann, Annika, Casper Steenholdt, Ole Haagen Nielsen, & Kim B. Jensen. (2024). Immune cell-derived signals governing epithelial phenotypes in homeostasis and inflammation. Trends in Molecular Medicine. 30(3). 239–251. 12 indexed citations
9.
10.
Steenholdt, Casper, Klaus Bendtzen, Jørn Brynskov, & Mark Ainsworth. (2016). Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies. Inflammatory Bowel Diseases. 22(8). 1999–2015. 72 indexed citations
11.
Steenholdt, Casper, Klaus Bendtzen, Jørn Brynskov, et al.. (2015). P471. Infliximab trough levels are lower in patients with acute severe, compared to moderate-severe ulcerative colitis patients. Journal of Crohn s and Colitis. 9(suppl 1). S314–S315. 1 indexed citations
12.
Steenholdt, Casper, et al.. (2015). Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy. The American Journal of Gastroenterology. 110(11). 1526–1532. 19 indexed citations
13.
14.
Steenholdt, Casper, Jørn Brynskov, Ole Østergaard Thomsen, et al.. (2013). Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial. Gut. 63(6). 919–927. 361 indexed citations breakdown →
15.
Steenholdt, Casper, et al.. (2012). Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease. Inflammatory Bowel Diseases. 18(12). 2209–2217. 85 indexed citations
16.
Lallemand, Christophe, Casper Steenholdt, Klaus Bendtzen, et al.. (2011). Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists. Journal of Immunological Methods. 373(1-2). 229–239. 82 indexed citations
17.
Steenholdt, Casper, Morten Svenson, Klaus Bendtzen, et al.. (2011). Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease. Journal of Crohn s and Colitis. 6(1). 108–111. 56 indexed citations
18.
Steenholdt, Casper, et al.. (2011). Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31. Journal of Crohn s and Colitis. 6(3). 358–361. 27 indexed citations
19.
Steenholdt, Casper, Morten Svenson, Klaus Bendtzen, et al.. (2011). Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 34(1). 51–58. 124 indexed citations
20.
Steenholdt, Casper, Klaus Bendtzen, Jørn Brynskov, Ole Østergaard Thomsen, & Mark Ainsworth. (2010). Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease. Scandinavian Journal of Gastroenterology. 46(3). 310–318. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bella Ungar Breakdown of academic impact, for papers by Sofie Joossens Breakdown of academic impact, for papers by Bruce Salzberg Breakdown of academic impact, for papers by A. Cassinotti Breakdown of academic impact, for papers by Stephan Targan Breakdown of academic impact, for papers by Xavier Hébuterne Breakdown of academic impact, for papers by Liesbet Henckaerts Breakdown of academic impact, for papers by Sophie Candon Breakdown of academic impact, for papers by Fabian Schnitzler Breakdown of academic impact, for papers by Benjamin Pariente
Rankless by CCL
2026